Exploring the Effect of Footbaths on Increasing the Success Rates in Vitro Fertilization
1 other identifier
interventional
80
1 country
1
Brief Summary
To evaluate the effectiveness of warm-water footbaths in enhancing pregnancy rates during IVF and to explore the underlying mechanisms involved.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 30, 2024
CompletedStudy Start
First participant enrolled
October 1, 2024
CompletedFirst Posted
Study publicly available on registry
October 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2025
CompletedOctober 3, 2024
October 1, 2024
9 months
September 30, 2024
October 2, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
pregnancy rate
IVF success rates in infertile women
28 days
Study Arms (2)
intervation
EXPERIMENTALParticipants in the intervention group will immerse their feet up to 10 cm into water inside a collapsible plastic container, maintaining a temperature of 40°C for 30 minutes every night, one hour before usual bedtime (between 21:00 and 22:00), starting from the first day of the menstrual cycle (MC) and continuing for 28 days.
usual care
NO INTERVENTIONclinical usual care
Interventions
before night sleep, takes 30 mins, starting from the first day of the menstrual cycle (MC) and continuing for 28 days.
Eligibility Criteria
You may qualify if:
- women aged 18\~45 years
- diagnosed with male factor infertility
- tubal factor infertility, or unexplained infertility, and undergoing an IVF treatment.
You may not qualify if:
- participants having adenomyosis, severe endometriosis
- a history of more than two IVF treatments
- any comorbidity or uncontrolled systemic diseases such as hypertension, diabetes, chronic heart disease or chronic renal disease that can affect the treatment process.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taipei University of Nursing and Health Sciences
Taipei, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chi-Hong Ho, PhD
Taipei Veterans General Hospital, Taiwan
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 30, 2024
First Posted
October 3, 2024
Study Start
October 1, 2024
Primary Completion
July 1, 2025
Study Completion
October 1, 2025
Last Updated
October 3, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share